科兴制药(688136.SH)向香港联交所递交H股发行上市申请并刊发申请资料

Core Viewpoint - The company, Sinovac Biotech (688136.SH), has submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange on November 6, 2025 [1] Group 1 - The application materials were published on the Hong Kong Stock Exchange website on the same day [1] - The materials were prepared in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange [1] - The information contained in the application is a draft version and may be updated or revised [1]